- Home
- COGT vs ACEL Comparison
COGT vs ACEL Comparison
Compare COGT & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- ACEL
- Stock Information
- Founded
- COGT 2014
- ACEL 2009
- Country
- COGT United States
- ACEL United States
- Employees
- COGT N/A
- ACEL N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- ACEL Services-Misc. Amusement & Recreation
- Sector
- COGT Health Care
- ACEL Consumer Discretionary
- Exchange
- COGT Nasdaq
- ACEL Nasdaq
- Market Cap
- COGT 900.3M
- ACEL 925.5M
- IPO Year
- COGT 2018
- ACEL N/A
- Fundamental
- Price
- COGT $7.90
- ACEL $11.32
- Analyst Decision
- COGT Buy
- ACEL Strong Buy
- Analyst Count
- COGT 6
- ACEL 1
- Target Price
- COGT $14.20
- ACEL $16.00
- AVG Volume (30 Days)
- COGT 1.7M
- ACEL 299.1K
- Earning Date
- COGT 11-12-2024
- ACEL 10-30-2024
- Dividend Yield
- COGT N/A
- ACEL N/A
- EPS Growth
- COGT N/A
- ACEL 4.41
- EPS
- COGT N/A
- ACEL 0.51
- Revenue
- COGT N/A
- ACEL $1,210,525,000.00
- Revenue This Year
- COGT N/A
- ACEL $6.12
- Revenue Next Year
- COGT N/A
- ACEL $2.74
- P/E Ratio
- COGT N/A
- ACEL $22.37
- Revenue Growth
- COGT N/A
- ACEL 5.13
- 52 Week Low
- COGT $4.28
- ACEL $9.37
- 52 Week High
- COGT $12.61
- ACEL $12.96
- Technical
- Relative Strength Index (RSI)
- COGT 32.81
- ACEL 42.35
- Support Level
- COGT $7.94
- ACEL $11.22
- Resistance Level
- COGT $8.56
- ACEL $12.10
- Average True Range (ATR)
- COGT 0.60
- ACEL 0.34
- MACD
- COGT -0.06
- ACEL -0.08
- Stochastic Oscillator
- COGT 9.60
- ACEL 10.34
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming operator in the United States. It is engaged in the installation, maintenance, and operation of video gaming terminals. The company offers products to restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It operates slot machines and amusement equipment. The company generates a majority of its revenue from net gaming. Net gaming revenue represents net cash received from gaming activities, which is the difference between gaming wins and losses. Net gaming revenue includes the amount earned by location partners and is recognized at the time of gaming play.